Related Experiment Videos
Gangliosides in children with autism
A Lekman1, O Skjeldal, E Sponheim
1Department of Clinical Neuroscience, University of Gothenburg, Sweden.
Acta Paediatrica (Oslo, Norway : 1992)
|July 1, 1995
Summary
Children with autism showed higher levels of brain gangliosides (GM1, GD1a, GD1b, GT1b) in cerebrospinal fluid (CSF). This suggests increased synaptic activity in autism, differing from other neurological disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Developmental Disorders
Background:
- Gangliosides (GM1, GD1a, GD1b, GT1b) are key markers of neuronal membranes.
- These molecules play roles in synaptic transmission and neuronal activity.
Purpose of the Study:
- To investigate ganglioside concentrations in cerebrospinal fluid (CSF) of children with autism.
- To compare these levels with those in healthy controls and children with other neurological disorders.
Main Methods:
- Cerebrospinal fluid (CSF) samples were collected from 20 children with autism and 25 controls.
- Ganglioside concentrations (GM1, GD1a, GD1b, GT1b) were measured in these samples.
- Comparison included age-matched controls and children with non-progressive neurological disorders.
Main Results:
- Significantly elevated levels of GM1, GD1a, GD1b, and GT1b were found in children with autism.
- Autism group showed higher ganglioside levels compared to both control groups.
- No significant differences were noted between autism and other neurological disorder groups for gangliosides.
Conclusions:
- Increased CSF ganglioside levels in autism suggest heightened synaptic activity.
- This finding may indicate a distinct neurobiological mechanism in autism spectrum disorder.
- Gangliosides could serve as potential biomarkers for synaptic dysfunction in autism.